D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
Snowflake
SNOW
|
+$429M |
| 3 |
Citigroup
C
|
+$383M |
| 4 |
Oracle
ORCL
|
+$365M |
| 5 |
Sea Limited
SE
|
+$360M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$597M |
| 2 |
Apple
AAPL
|
+$579M |
| 3 |
Mastercard
MA
|
+$525M |
| 4 |
Walt Disney
DIS
|
+$428M |
| 5 |
Booking.com
BKNG
|
+$416M |
Sector Composition
| 1 | Technology | 19.98% |
| 2 | Consumer Discretionary | 13.5% |
| 3 | Financials | 10.53% |
| 4 | Healthcare | 10.18% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Trinity Industries
TRN
$2.28B
| $10.1M | 0.01% |
333,958
-85,193
| -20% | -$2.57M |
|
1002
IDEX
IEX
$12.1B
| $10M | 0.01% |
42,449
+33,438
| +371% | +$7.9M |
|
|
LFTR
1003
DELISTED
Lefteris Acquisition Corp. Class A Common Stock
LFTR
| $10M | 0.01% |
1,023,111
+163,109
| +19% | +$1.6M |
|
|
KAHC
1004
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
| $10M | 0.01% |
1,028,806
+221,164
| +27% | +$2.15M |
|
|
NOAC
1005
DELISTED
Natural Order Acquisition Corp. Common Stock
NOAC
| $10M | 0.01% |
1,019,685
+689,945
| +209% | +$6.78M |
|
1006
Republic Services
RSG
$71.3B
| $9.95M | 0.01% |
71,352
-119,606
| -63% | -$16.7M |
|
|
SAGAU
1007
DELISTED
Sagaliam Acquisition Corp. Units
SAGAU
| $9.93M | 0.01% |
+990,000
| New | +$9.93M |
|
1008
Independence Realty Trust
IRT
$4.07B
| $9.91M | 0.01% |
+383,719
| New | +$9.91M |
|
1009
Designer Brands
DBI
$225M
| $9.9M | 0.01% |
696,992
-853,677
| -55% | -$12.1M |
|
|
EPHY
1010
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
| $9.88M | 0.01% |
1,012,183
+587,478
| +138% | +$5.73M |
|
1011
Markel Group
MKL
$24.7B
| $9.88M | 0.01% |
8,005
+6,025
| +304% | +$7.43M |
|
1012
Colliers International
CIGI
$8.48B
| $9.84M | 0.01% |
66,000
+14,500
| +28% | +$2.16M |
|
1013
Cars.com
CARS
$829M
| $9.82M | 0.01% |
610,502
-303,086
| -33% | -$4.88M |
|
1014
Vanda Pharmaceuticals
VNDA
$266M
| $9.82M | 0.01% |
626,060
-199,840
| -24% | -$3.14M |
|
|
ISLE
1015
DELISTED
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
| $9.82M | 0.01% |
997,478
+255,233
| +34% | +$2.51M |
|
1016
TriNet
TNET
$3.35B
| $9.8M | 0.01% |
102,918
+93,652
| +1,011% | +$8.92M |
|
|
CRZN
1017
DELISTED
Corazon Capital V838 Monoceros Corp Class A Ordinary Shares
CRZN
| $9.78M | 0.01% |
1,001,843
+251,843
| +34% | +$2.46M |
|
1018
Ero Copper
ERO
$1.75B
| $9.76M | 0.01% |
639,300
+143,900
| +29% | +$2.2M |
|
1019
General Dynamics
GD
$87.7B
| $9.76M | 0.01% |
46,816
+15,416
| +49% | +$3.21M |
|
1020
Accel Entertainment
ACEL
$938M
| $9.75M | 0.01% |
748,601
+78,094
| +12% | +$1.02M |
|
1021
Ryerson Holding
RYI
$723M
| $9.74M | 0.01% |
373,819
-37,911
| -9% | -$988K |
|
|
HCAR
1022
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
| $9.7M | 0.01% |
+993,959
| New | +$9.7M |
|
1023
Dr. Reddy's Laboratories
RDY
$12.2B
| $9.7M | 0.01% |
741,335
+298,610
| +67% | +$3.91M |
|
1024
Genpact
G
$7.41B
| $9.7M | 0.01% |
182,682
-30,810
| -14% | -$1.64M |
|
1025
Theravance Biopharma
TBPH
$720M
| $9.68M | 0.01% |
876,463
+456,412
| +109% | +$5.04M |
|